注射器・注射針 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の注射器・注射針の市場規模は、2024年～2030年の予測期間にCAGRで6.73%の成長が見込まれます。注射器・注射針の需要は主に、HIV、腸チフスなどの感染症の有病率の増加、インフルエンザ、COVID-19などの伝染病やパンデミックの流行、エンドユーザーにとっての注射器・注射針の安全性、入手性、使いやすさの向上への関心の高まりなどの主な要因によって促進されており、これらが2024年～2030年の予測期間に市場成長にプラスの影響を生み出す見込みです。

注射器・注射針の市場力学

世界保健機関（WHO）（2022）によると、2020年に世界で約3,770万人がヒト免疫不全ウイルス（HIV）に罹患しています。注射器・注射針は、診断目的で血液やその他のサンプルを採取する際に使用されます。例えば、核酸検査（NAT）のようなHIV検出に向けた診断検査では、適切な注射器・注射針を使用して静脈から血液を採取し、ウイルスの存在を検査するプロセスが含まれます。

糖尿病などの生活習慣病では、インスリン注射器や無針注射による血糖値管理が必要です。IDF Diabetes Atlas（2023）の統計によると、2021年に5億3,700万人の成人（10人に1人）が糖尿病を患っています。注射器・注射針を使った適時のインスリン注射という形のインスリン療法は、全体的な血糖値の調整に役立つため、脳卒中や心臓発作などの可能性を減らす可能性があります。

さらに、世界中での伝染病やパンデミックの発生の増加が注射器・注射針市場の成長を促進しています。これは、世界の人々に保護を提供し、免疫を引き起こすためのワクチン接種の予測期間における高い需要に起因します。例えば、WHO（2023）によると、2022年12月末現在、世界中で約277万回分のCOVID-19ワクチンが投与されました。

上記のすべての要因とワクチン投与は、注射器・注射針を通じて投与されており、将来も同様に投与されるため、予測期間に注射器・注射針の全体的な需要が増加します。

したがって、診断、治療、予防接種に向けた注射器・注射針の採用が増加しており、2023年～2028年の予測期間に注射器・注射針市場の全体的な市場成長を促進すると見込まれます。

注射器・注射針の製品開発活動の増加は、さらに世界の注射器・注射針市場の成長を助けると予測されます。2021年6月、怪我を防ぐために、Hindustan Syringes and Medical Devices Ltd.は、使い捨ての安全針を発表しました。「taking care of those who take care of us」というキャッチフレーズで発売された使い捨ての滅菌針は、医療従事者が意図せずにNSI（針刺し損傷）を起こす可能性を防ぐものとされています。

しかし、注射器・注射針の不適切な使用に伴う合併症や、交差汚染のリスク、代替の投与方法などが、注射器・注射針市場の成長の障壁となる可能性があります。

COVID-19パンデミックは、ワクチン発見に向けたさまざまな臨床試験や研究試験が注射器・注射針の使用に関与していたため、注射器・注射針市場全体の成長にプラスの影響を与えました。最初のワクチン接種が商業的に開始された後のCOVID-19パンデミックの後期には、注射器・注射針を通して投与されるワクチンを使用して、大量の人々が予防接種を受けました。病院、診療所、その他の医療施設は、COVID-19に罹患した患者へのワクチンの管理と投与で過重な負担を強いられていました。COVID-19パンデミック中、そして今後、免疫を提供し、さらなるパンデミックや感染症から患者を守るために、注射器・注射針の注意すべき需要があるため、注射器・注射針の市場需要は、予測期間の今後数年間にさらなる成長が見込まれます。

当レポートでは、世界の注射器・注射針市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 注射器・注射針市場レポートのイントロダクション

第2章 注射器・注射針市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 注射器・注射針市場の主な要因の分析

• 注射器・注射針市場の促進要因
• 注射器・注射針市場の抑制要因と課題
• 注射器・注射針市場の機会

第5章 注射器・注射針市場のポーターのファイブフォース分析

第6章 注射器・注射針の市場レイアウト

• 用途別
  • 再使用可能
  • 使い捨て
• タイプ別
  • 注射器
  • 注射針
• エンドユーザー別
  • 病院
  • 専門クリニック
  • その他
• 地域
  • 北米の注射器・注射針の市場規模（2021年～2030年）
  • 欧州の注射器・注射針の市場規模（2021年～2030年）
  • アジア太平洋の注射器・注射針の市場規模（2021年～2030年）
  • その他の地域の注射器・注射針の市場規模（2021年～2030年）

第7章 注射器・注射針市場の企業と製品のプロファイル

• Becton, Dickinson, and Company
• B. Braun SE
• Terumo Medical Corporation
• Gerresheimer AG
• ICU Medical, Inc.
• Cardinal Health
• Hindustan Syringes & Medical Devices Ltd.
• Nipro Medical Corporation
• SCHOTT PHARMA AG & CO. KGAA
• Catalent, Inc
• DeRoyal Industries, Inc.
• Connecticut Hypodermics, Inc.
• Albert David Ltd
• PharmaJet
• CODAN Companies
• Medtronic plc
• VOGT MEDICAL
• Lifelong Meditech Private Limited
• Hi-Tech Syringes
• F. Hoffmann-La Roche AG

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Syringes and Needles Market in Global (2021-2030)
• Table 3: Syringes and Needles Market in Global by Usage (2021-2030)
• Table 4: Syringes and Needles Market in Global by Type (2021-2030)
• Table 5: Syringes and Needles Market in Global by End-User (2021-2030)
• Table 6: Syringes and Needles Market in Global by Geography (2021-2030)
• Table 7: Syringes and Needles Market in North America (2021-2030)
• Table 8: Syringes and Needles Market in North America by Country (2021-2030)
• Table 9: Syringes and Needles Market in the US (2021-2030)
• Table 10: Syringes and Needles Market in Canada (2021-2030)
• Table 11: Syringes and Needles Market in Mexico (2021-2030)
• Table 12: Syringes and Needles Market in Europe (2021-2030)
• Table 13: Syringes and Needles Market in Europe by Country (2021-2030)
• Table 14: Syringes and Needles Market in France (2021-2030)
• Table 15: Syringes and Needles Market in Germany (2021-2030)
• Table 16: Syringes and Needles Market in the United Kingdom (2021-2030)
• Table 17: Syringes and Needles Market in Italy (2021-2030)
• Table 18: Syringes and Needles Market in Spain (2021-2030)
• Table 19: Syringes and Needles Market in the Rest of Europe (2021-2030)
• Table 20: Syringes and Needles Market in Asia-Pacific (2021-2030)
• Table 21: Syringes and Needles Market in Asia-Pacific by Country (2021-2030)
• Table 22: Syringes and Needles Market in China (2021-2030)
• Table 23: Syringes and Needles Market in Japan (2021-2030)
• Table 24: Syringes and Needles Market in India (2021-2030)
• Table 25: Syringes and Needles Market in Australia (2021-2030)
• Table 26: Syringes and Needles Market in South Korea (2021-2030)
• Table 27: Syringes and Needles Market in Rest of Asia-Pacific (2021-2030)
• Table 28: Syringes and Needles Market in the Rest of the World (2021-2030)
• Table 29: Syringes and Needles Market in the Middle East (2021-2030)
• Table 30: Syringes and Needles Market in Africa (2021-2030)
• Table 31: Syringes and Needles Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Syringes and Needles Market in Global (2021-2030)
• Figure 3: Syringes and Needles Market in Global by Usage (2021-2030)
• Figure 4: Syringes and Needles Market in Global by Type (2021-2030)
• Figure 5: Syringes and Needles Market in Global by End-User (2021-2030)
• Figure 6: Syringes and Needles Market in Global by Geography (2021-2030)
• Figure 7: Syringes and Needles Market in North America (2021-2030)
• Figure 8: Syringes and Needles Market in North America by Country (2021-2030)
• Figure 9: Syringes and Needles Market in the US (2021-2030)
• Figure 10: Syringes and Needles Market in Canada (2021-2030)
• Figure 11: Syringes and Needles Market in Mexico (2021-2030)
• Figure 12: Syringes and Needles Market in Europe (2021-2030)
• Figure 13: Syringes and Needles Market in Europe by Country (2021-2030)
• Figure 14: Syringes and Needles Market in France (2021-2030)
• Figure 15: Syringes and Needles Market in Germany (2021-2030)
• Figure 16: Syringes and Needles Market in the United Kingdom (2021-2030)
• Figure 17: Syringes and Needles Market in Italy (2021-2030)
• Figure 18: Syringes and Needles Market in Spain (2021-2030)
• Figure 19: Syringes and Needles Market in the Rest of Europe (2021-2030)
• Figure 20: Syringes and Needles Market in Asia-Pacific (2021-2030)
• Figure 21: Syringes and Needles Market in Asia-Pacific by Country (2021-2030)
• Figure 22: Syringes and Needles Market in China (2021-2030)
• Figure 23: Syringes and Needles Market in Japan (2021-2030)
• Figure 24: Syringes and Needles Market in India (2021-2030)
• Figure 25: Syringes and Needles Market in Australia (2021-2030)
• Figure 26: Syringes and Needles Market in South Korea (2021-2030)
• Figure 27: Syringes and Needles Market in Rest of Asia-Pacific (2021-2030)
• Figure 28: Syringes and Needles Market in the Rest of the World (2021-2030)
• Figure 29: Syringes and Needles Market in the Middle East (2021-2030)
• Figure 30: Syringes and Needles Market in Africa (2021-2030)
• Figure 31: Syringes and Needles Market in South America (2021-2030)
• Figure 32: Market Drivers
• Figure 33: Market Barriers
• Figure 34: Marker Opportunities
• Figure 35: PORTER'S Five Force Analysis

Syringes And Needles Market By Usage (Disposable And Reusable), By Type (Syringes [Standard Syringes, Insulin Syringes, Prefilled Flush Syringes, Leur-Lock Syringes, And Others] And Needles [Hypodermic Needles, Pen Needles, And Others]), By End-User (Hospitals, Speciality Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of infectious diseases and the growing focus on improving the safety, affordability, and usability of syringes and needles for end-users, among others

The global syringes and needles market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030. The demand for syringes and needles is primarily being boosted owing to key factors such as the increasing prevalence of infectious diseases such as HIV, typhoid, and others, rising incidences of epidemics and pandemics such as influenza, COVID-19, and the growing focus on improving the safety, affordability, and usability of syringes and needles for end-users, among other factors are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

Syringes And Needles Market Dynamics:

According to the World Health Organization (WHO) 2022, globally around 37.7 million people were suffering from human immunodeficiency virus (HIV) in the year 2020. The syringes and needles are employed in the collection of blood and other samples for diagnostic purposes. For instance, the diagnostic test for HIV detection such as the Nucleic Acid Test (NAT), involves a process where the blood is drawn from the vein using an appropriate syringe and needle and is tested for the presence of the virus.

Lifestyle-related disorders such as diabetes, require blood sugar level management through insulin syringes and other needle-free injections applicable. As per statistics by the IDF Diabetes Atlas (2023), 537 million adults (1 in 10) were living with diabetes in 2021. Insulin therapies in the form of timely insulin injections through syringes and needles help in the regulation of overall blood sugar levels, thus possibly reducing the chances of stroke, and heart attacks, among others.

Further, the rising incidences of epidemics and pandemics across the world are going to boost the market growth for syringes and needles, owing to the greater demand for vaccination doses to provide protection and induce immunity among the global population during the forecast period. For instance, as per WHO 2023, globally at the end of December 2022, around 2.77 million doses of COVID- 19 vaccine were administered across the globe.

All the above-stated factors and figures for the total number of vaccine doses have been administered through syringes and needles and shall be delivered in the same way in the future as well, thus increasing the overall demand for syringes and needles during the forecast period.

Hence, the increasing adoption of syringes and needles for diagnostic, treatment, and immunizing purposes, is thereby anticipated to propel the overall market growth of the syringes and needles market during the forecast period from 2023-2028.

The increasing product development activities for syringes and needles are further expected to aid in the growth of the global syringes and needles market. In June 2021, to prevent injuries, Hindustan Syringes and Medical Devices Ltd. introduced a single-use disposal safety needle; the single-use sterile needles, launched with the tagline "taking care of those who take care of us," and are supposed to prevent healthcare personnel from the possibility of unintentional NSIs (Needle stick injury).

However, complications associated with the improper use of syringes and needles, risks of cross-contamination, and alternate delivery methods, among others may act as barriers to the syringes and needles market growth.

The COVID-19 pandemic had a positive impact on the overall market growth of syringes and needles as various clinical and research trials for vaccine discovery involved the use of syringes and needles. During the late stages of the coronavirus pandemic after the commercial launch of the first vaccination, large masses of people were immunized using vaccine doses administered through syringes and needles. The hospitals, clinics, and other medical facilities were overburdened with managing and administering vaccine doses to patients affected by COVID-19. Due to an alarming demand for syringes and needles during the COVID-19 pandemic and in times to come to deliver immunity and to protect patients from further pandemics and infections, the market demand for syringes and needles is expected to further growth in the upcoming years during the forecast period.

Syringes And Needles Market Segment Analysis:

Syringes and Needles Market by Usage (Disposable and Reusable), Type (Syringes [Standard Syringes, Insulin Syringes, Prefilled Flush Syringes, Leur-Lock Syringes, and Others] and Needles [Hypodermic Needles, Pen Needles, and Others]), End-User (Hospitals, Speciality Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the type segment of the syringes and needles market, the pen needles category is expected to amass a significant revenue share in the year 2023. This can be attributed to the large patient population base associated with diabetes, advantages, along with the increasing product development activities such as product launches in the pen needles category during the given forecast period.

According to statistics by the IDF Diabetes Atlas Tenth edition (2021), the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The source further stated that more than 1.2 million children and adolescents (0-19 years) were living with type 1 diabetes in 2021. The presence of such a huge population of diabetes-affected individuals requires quality products for insulin delivery for diabetes management.

Though pen needles can be more expensive than a vial and syringe, they are more convenient, less painful, easily storable, and transportable. They essentially combine the vial and syringe, allowing greater dose accuracy and easier administration of doses.

Along with this, the growing focus of manufacturers on designing and developing new pen needles for insulin delivery is going to accelerate the demand for the same. For example, in May 2022, Roche Diabetes Care India launched ACCU-FINE, quality pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes. The makers of ACCU-CHEK aim to make the process of insulin delivery easier thereby leading to better diabetes management for diabetic people.

Therefore, the benefits associated with pen needles along with product launches would increase their demand in the market, which will drive the growth of the overall global syringes and needles market during the forecast period.

North America is expected to dominate the overall Syringes And Needles Market:

Among all the regions, North America is estimated to account for the largest share of the global Syringes and Needles market in the year 2023. This domination is due to factors such as the presence of a wide end-user patient base associated with cardiovascular diseases, diabetes, and others, rising research and development activities in the region, surging launch and approval of new devices is also driving the market growth of syringes and needles in North America.

As per statistics by the Centers for Disease Control and Prevention (2021), about 20.1 million adults aged 20 had coronary artery disease in 2021. The source further stated that coronary heart disease is the most common type of heart disease, killing 382,820 people in 2020. The diagnosis, therapies, and treatment for coronary heart disease require the use of syringes and needles. Also, according to the Diabetes Research Institute (2023), 37.3 million people, or 11.3% of the US population, were affected by diabetes in 2022. The source further stated that an estimated 28.7 million people - or 28.5% of the population had been diagnosed with diabetes in the same year, whereas nearly 8.5 million people had diabetes but were not diagnosed.

Thus, the increasing number of patients with cardiovascular, diabetes, and other diseases may increase the demand for syringes and needles for their diagnosis, treatment, and other associated procedures during the forecast period.

The product development activities and product approvals are further expected to drive the demand for syringes and needles in the region. For instance, in March 2023, Techdow USA Inc., a growing market leader, and vertically integrated generic injectables company, announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the US market.

Therefore, the interplay of all the above-mentioned factors is expected to drive the market growth for syringes and needles in the region during the forecast period from 2022-2027.

Syringes And Needles Market Key Players:

Some of the key market players operating in the syringes and needles market include Becton, Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Gerresheimer AG, ICU Medical, Inc., Cardinal Health, Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation, SCHOTT PHARMA AG & CO. KGAA, Catalent, Inc, DeRoyal Industries, Inc., Connecticut Hypodermics, Inc., Albert David Ltd, PharmaJet, CODAN Companies, Medtronic plc, VOGT MEDICAL, Lifelong Meditech Private Limited, Hi-Tech Syringes, F. Hoffmann-La Roche AG, and others.

Recent Developmental Activities in the Syringes And Needles Market:

In March 2023, Nexus Pharmaceuticals, Inc. announced that it received US Food and Drug Administration (FDA) approval for EMERPHED® (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available.

In September 2022, BD (Becton, Dickinson, and Company), a leading global medical technology company, introduced a next-generation glass pre-fillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity. The new BD Effivax Glass Prefillable Syringe has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing.

In July 2021, Fresenius Kabi launched a ready-to-administer fentanyl product prefilled syringe. The 1-mL presentation is said to be unique in the U.S. market and is designed to cut waste and diversion by reducing the potential for errors. Fresenius eliminated assembly steps to streamline point-of-care preparation, reduce the potential for waste and make it easier for healthcare professionals to dispense the prescribed dose.

Key Takeaways from the Syringes And Needles Market Report Study

Market size analysis for current syringes and needles market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global Syringes and Needles Market.

Various opportunities available for the other competitor in the syringes and needles market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current syringes and needles market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for syringes and needles market growth in the coming future?

Target Audience who can be benefited from this Syringes And Needles Market Report Study

Syringes and needles products providers

Research organizations and consulting companies

Syringes and needles-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in syringes and needles

Various end-users who want to know more about the syringes and needles market and the latest technological developments in the syringes and needles market.

Frequently Asked Questions for the Syringes And Needles Market:

1. What are Syringes and Needles?

Syringes and needles are sterile medical supplies used to inject solutions into the body or remove secretions. A syringe is a calibrated glass or plastic cylinder with an opening that connects to a needle and a plunger at one end. The needle is a metal tube that is hollow and has a pointy tip. A syringe and needle may also be used to remove various body fluids, most frequently blood from veins or tissue fluid from swollen joints.

2. What is the market for Global Syringes and Needles?

The global syringes and needles market is estimated to grow at a CAGR of 6.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Syringes and Needles market?

The demand for syringes and needles is primarily being boosted owing to key factors such as the increasing prevalence of infectious diseases such as malaria, typhoid, and others, rising incidences of epidemics and pandemics such as influenza, COVID-19, and the growing focus on improving the safety, affordability, and usability of syringes and needles for end-users, among other factors are expected to create a positive impact on the market growth during the forecast period from 2024-2030.

4. Who are the key players operating in the global Syringes and Needles market?

Some of the key market players operating in the syringes and needles market include Becton, Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Gerresheimer AG, ICU Medical, Inc., Cardinal Health, Hindustan Syringes & Medical Devices Ltd., Nipro Medical Corporation, SCHOTT PHARMA AG & CO. KGAA, Catalent, Inc, DeRoyal Industries, Inc., Connecticut Hypodermics, Inc., Albert David Ltd, PharmaJet, CODAN Companies, Medtronic plc, VOGT MEDICAL, Lifelong Meditech Private Limited, Hi-Tech Syringes, F. Hoffmann-La Roche AG, and others.

5. Which region has the highest share in the Syringes and Needles market?

North America is expected to dominate the overall Syringes and Needles market during the forecast period from 2024-2030. This domination is due to factors such as the presence of a wide end-user patient base associated with cardiovascular diseases, diabetes, and others, rising research and development activities in the region, surging launch and approval of new devices is also driving the market growth of syringes and needles in North America.

Table of Contents

1.Syringes and Needles Market Report Introduction

2. Syringes and Needles Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Syringes and Needles Market Key Factors Analysis

• 4.1. Syringes and Needles Market Drivers
  • 4.1.1. Increasing prevalence of infectious diseases and lifestyle disorders
  • 4.1.2. The rising demand for vaccinations for mass immunization owing to the sudden incidence of epidemics and pandemics
  • 4.1.3. The growing focus on improving the safety, affordability, and usability of syringes and needles for end-users
• 4.2. Syringes and Needles Market Restraints and Challenges
  • 4.2.1. Complications associated with the improper use of syringes and needles,
  • 4.2.2. Risks of cross-contamination and the presence of alternate delivery methods
• 4.3. Syringes and Needles Market Opportunities
  • 4.3.1. Increasing research and development activities to improve the precision and delivery of syringes and needles
  • 4.3.2. Integration of artificial intelligence (AI) in syringes and needles

5. Syringes and Needles Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Syringes and Needles Market Layout

• 6.1. By Usage
  • 6.1.1. Reusable
  • 6.1.2. Disposable
• 6.2. By Type
  • 6.2.1. Syringes
    • 6.2.1.1. Standard Syringes
    • 6.2.1.2. Insulin Syringes
    • 6.2.1.3. Prefilled Flush Syringes
    • 6.2.1.4. Leur-Lock Syringes
    • 6.2.1.5. Others
  • 6.2.2. Needles
    • 6.2.2.1. Hypodermic Needles
    • 6.2.2.2. Pen Needles
    • 6.2.2.3. Others
• 6.3. By End-User
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. By Geography
  • 6.4.1. North America Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.1.1. United States Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.1.2. Canada Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.1.3. Mexico Syringes and Needles Market Size in USD million (2021-2030)
  • 6.4.2. Europe Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.2.1. France Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.2.2. Germany Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.2.3. United Kingdom Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.2.4. Italy Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.2.5. Spain Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.2.6. Rest of Europe Syringes and Needles Market Size in USD million (2021-2030)
  • 6.4.3. Asia-Pacific Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.3.1. China Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.3.2. Japan Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.3.3. India Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.3.4. Australia Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.3.5. South Korea Syringes and Needles Market Size in USD million (2021-2030)
    • 6.4.3.6. Rest of Asia-Pacific Syringes and Needles Market Size in USD million (2021-2030)
  • 6.4.4. Rest of the World (RoW) Syringes and Needles Market Size in USD million (2021-2030)
    • 7.3.4.1. Middle East Syringes and Needles Market Size in USD million (2021-2030)
    • 7.3.4.2. Africa Syringes and Needles Market Size in USD million (2021-2030)
    • 7.3.4.3. South America Syringes and Needles Market Size in USD million (2021-2030)

7. Syringes and Needles Market Company and Product Profiles

• 7.1. Becton, Dickinson, and Company
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. B. Braun SE
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Terumo Medical Corporation
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Gerresheimer AG
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. ICU Medical, Inc.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Cardinal Health
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Hindustan Syringes & Medical Devices Ltd.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Nipro Medical Corporation
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. SCHOTT PHARMA AG & CO. KGAA
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Catalent, Inc
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. DeRoyal Industries, Inc.
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Connecticut Hypodermics, Inc.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Albert David Ltd
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. PharmaJet
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. CODAN Companies
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Medtronic plc
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. VOGT MEDICAL
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. Lifelong Meditech Private Limited
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Hi-Tech Syringes
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. F. Hoffmann-La Roche AG

7.20.1.Company Overview

7.20.2.Company Snapshot

7.20.3.Financial Overview

7.20.4.Product Listing

7.20.5.Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us